Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENVISTA HOLDINGS CORPORATION

(NVST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Envista : Agrees to Sell KaVo Treatment Unit And Instrument Business For up to $455 Million

09/07/2021 | 09:23am EDT


ę MT Newswires 2021
All news about ENVISTA HOLDINGS CORPORATION
10/26BofA Securities Upgrades Envista Holdings to Buy From Neutral; Price Target is $48
MT
10/11ENVISTA : Schedules Third Quarter 2021 Earnings Call
PR
09/07ENVISTA : Agrees to Sell KaVo Treatment Unit And Instrument Business For up to $455 Millio..
MT
09/07ENVISTA : ANNOUNCES INTENDED SALE OF KAVO TREAMENT UNIT & INSTRUMENT BUSINESS TO PLANMECA ..
PU
09/07ENVISTA HOLDINGS CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosu..
AQ
09/07ENVISTA : Announces Intended Sale Of KaVo Treatment Unit & Instrument Business To Planmeca
PR
09/07Planmeca Verwaltungs GmbH entered into a binding agreement to acquire KaVo Dental Treat..
CI
09/01ENVISTA : Announces Participation In Baird Global Healthcare Conference
PR
08/27ENVISTA HOLDINGS CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F..
AQ
08/27ENVISTA : SECOND AMENDED AND RESTATED BYLAWS OF (Form 8-K)
PU
More news
Analyst Recommendations on ENVISTA HOLDINGS CORPORATION
More recommendations
Financials (USD)
Sales 2021 2 810 M - -
Net income 2021 277 M - -
Net Debt 2021 690 M - -
P/E ratio 2021 24,1x
Yield 2021 -
Capitalization 6 226 M 6 226 M -
EV / Sales 2021 2,46x
EV / Sales 2022 2,30x
Nbr of Employees 12 400
Free-Float 99,6%
Chart ENVISTA HOLDINGS CORPORATION
Duration : Period :
Envista Holdings Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENVISTA HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 38,61 $
Average target price 50,20 $
Spread / Average Target 30,0%
EPS Revisions
Managers and Directors
Amir A. Aghdaei President, Chief Executive Officer & Director
Howard H. Yu Chief Financial Officer & Senior Vice President
R. Scott Huennekens Independent Chairman
Wendy Carruthers Independent Director
Christine A. Tsingos Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ENVISTA HOLDINGS CORPORATION14.47%6 226
ABBOTT LABORATORIES17.02%227 151
MEDTRONIC PLC5.90%166 948
BECTON, DICKINSON AND COMPANY-1.55%70 749
HOYA CORPORATION21.09%55 803
DEXCOM, INC.52.99%54 725